• Title

    Probing the mysteries of human health and disease.

  • Title Slide 2

    Vibrant biomedical research campus situated in the beautiful Sonoran Desert Ecosystem.

  • Title Slide 3

    Collaborative research environment harnessing leading-edge technology and training.

  • Student Slide

    Multidisciplinary program to train the next generation of biomedical scientists.

A multidisciplinary PhD program focused on outstanding scholarship in the fields of immunobiology, molecular biophysics, and cell biology

Home Page

Over 50 Faculty and 30 PhD Students

The Cellular and Molecular Medicine (CMM) and Immunobiology (IMB) graduate programs at the University of Arizona have merged to create the Graduate Program in Molecular Medicine (GPMM). GPMM is an interdepartmental, multidisciplinary training program that fosters the development of scientists and educators who are prepared for lifelong participation in research and other intellectual pursuits. With an emphasis on bridging basic and translational science, Molecular Medicine trainees receive advanced training in the theory and practice of biomedical science. There are opportunities to investigate human health and disease ranging from biophysical studies at the atomic level, to modeling critical cellular process in tractable systems, to clinical research. The exposure and skills that our trainees acquire prepare them for careers in biomedical research (including academia and the biotechnology industry), science education, journalism, and public policy.

Cell Biology

Cell Biology

To provide students with a foundation for understanding the cellular underpinnings of human health and disease, while advancing the field through hands-on, cutting-edge research.

Medical Biophysics

Medical Biophysics

Apply quantitative multi-disciplinary approaches to molecular and integrative biology with a goal to understand the biophysical basis of health and disease mechanisms, identify drugable targets and contribute to Precision Medicine.

Immunobiology

Immunobiology

Advance the insights into the rules of engagement that determine the outcome of host-pathogen interactions to develop future therapies for infectious, autoimmune and malignant diseases.

News

Article Accepted to the Journal of American Geriatric Society

Age-related changes in the clinical picture of Long COVID, Mindy J. Fain, Benjamin D. Horne, Leora I. Horwitz, (45 contributing authors), and Janko Ž. Nikolich, on behalf of the RECOVER consortium . J. Am. Geriatric Assoc. 2025 (in press)
Dr. Donata Vercelli Investigates the Remarkably Low Allergy Rates in the Amish Community

Donata Vercelli, MD, Regents Professor of Cellular and Molecular Medicine, is researching why Amish experience a dramatically lower rate of allergies, aiming to uncover insights that could help protect the broader population. Click to read more
Dr. Kelvin Pond Receives 2025 Project Cure CRC Young Investigator Accelerator Award

Kelvin Pond, PhD, Assistant Professor of Cellular and Molecular Medicine, received the 2025 Project Cure CRC Young Investigator Accelerator Award from the Colorectal Cancer Alliance. The awards consists of a total grant of $188K to support his project titled, “Dissection of PI3K and MAPK Dynamics in Patient-Derived Colorectal Cancer Organoids for Accelerating Therapeutic Development.”
Innovative Drug Discovery Venture from UA Research Lands $4 Million Seed Investment

Curtis Thorne, PhD, Associate Professor of Cellular and Molecular Medicine, co-founded a drug discovery company aimed at developing treatments for colorectal and other types of cancer. Click to read more

Upcoming Events

Sep
03
CMM Seminar - Dr. Natalia Ignatenko